Evidence map›Paper›PMID 39592855›Full record

ReviewNPJ digital medicine2024

A Primer on Reinforcement Learning in Medicine for Clinicians.

Pushkala Jayaraman, Jacob Desman, Moein Sabounchi, Girish N Nadkarni, Ankit Sakhuja

Abstract readReview
In one paragraph

Review in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Artificial Intelligence Across the Drug Development Lifecycle.Medical sciences (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pushkala JayaramanThe Charles Bronfman Institute for Personalized Medicine (CBIPM), Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-1159-8354
Jacob DesmanThe Charles Bronfman Institute for Personalized Medicine (CBIPM), Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-5411-6637
Moein SabounchiThe Charles Bronfman Institute for Personalized Medicine (CBIPM), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Girish N NadkarniThe Charles Bronfman Institute for Personalized Medicine (CBIPM), Icahn School of Medicine at Mount Sinai, New York, NY, USA. girish.nadkarni@mountsinai.org.ORCID http://orcid.org/0000-0001-6319-4314
Ankit SakhujaThe Charles Bronfman Institute for Personalized Medicine (CBIPM), Icahn School of Medicine at Mount Sinai, New York, NY, USA. ankit.sakhuja@mssm.edu.

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac SurgeryK08DK131286 · NIDDK · WEST VIRGINIA UNIVERSITY · PI Ankit Sakhuja · 2022 to 2026
$774k
NCATS NIH HHS UL1 TR004419NIDDK NIH HHS K08 DK131286U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) UL1TR004419U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) K08DK131286U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER) K08DK131286
6 · The paper itself

Abstract

Reinforcement Learning (RL) is a machine learning paradigm that enhances clinical decision-making for healthcare professionals by addressing uncertainties and optimizing sequential treatment strategies. RL leverages patient-data to create personalized treatment plans, improving outcomes and resource efficiency. This review introduces RL to a clinical audience, exploring core concepts, potential applications, and challenges in integrating RL into clinical practice, offering insights into efficient, personalized, and effective patient care.

Identifiers

PMID39592855
PMCPMC11599275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.